Skip to main content
. Author manuscript; available in PMC: 2019 Jun 10.
Published in final edited form as: Mol Pharm. 2019 Jan 17;16(2):607–617. doi: 10.1021/acs.molpharmaceut.8b00887

Fig. 4.

Fig. 4.

Clinical scoring data were analyzed by A.) disease onset by group, as determined by proportion of mice having exhibited any clinical score by the day of each time point, and B.) area under the scoring curve for each treatment group. (n = 12–15 mice/group, *p < 0.05, **p < 0.01, ***p < 0.001). Error bars are reported as standard deviation among samples.